Diabetes, Type I Clinical Trial
Official title:
Childhood Diabetes - Family Based Health Interventions for Child Health
Purpose of the study:
To compare three different regimes for children newly diagnosed with type 1 diabetes: (1)
traditional hospital based care, (2) intensive psychological support to the family, and (3)
home based family psychosocial support. A further aim is to identify families were the child
runs the risk of decreased metabolic control and to give those families increased support.
Specific objectives:
The main objectives of the study are:
1. to analyse the effects on child health of family-based home care compared to
traditional hospital-based care, and
2. to analyse the effects on child health of family-based psychological treatment compared
to traditional hospital-based treatment.
The main focus will be on child health and changes in child health. Several variables will
be collected for these purpose (see instruments, below), the main variable being the child's
metabolic control. We will also analyse effects on the amount and content of (1) parental
efforts (absenteeism from work; time use which is conditional on the child's diabetes etc),
and (2) formal health care utilisation of the home-based care and psychological treatment,
respectively, compared to traditional care.
Status | Recruiting |
Enrollment | 210 |
Est. completion date | December 2015 |
Est. primary completion date | September 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 3 Years to 15 Years |
Eligibility |
Inclusion Criteria: - children, aged 3 - 15 - newly diagnosed with diabetes mellitus - no other chronic illnesses - Swedish as mother tongue - no siblings with type 1 diabetes - not objects for social interventions Exclusion Criteria: |
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Sweden | Queen Silvia's Childrens' hospital | Gothenburg | |
Sweden | Lund University Childrens' hospital | Lund |
Lead Sponsor | Collaborator |
---|---|
Vardalinstitutet The Swedish Institute for Health Sciences | Lund University Hospital, Sahlgren´s University Hospital |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Primary Outcome Measure: the child's metabolic control as shown in HbA1C | 6 months, 1 year, 2 year, 5 year | No | |
Secondary | Quality of life, Satisfaction with care, Family impact and family climate, psychological variables, parental absenteeism from work; time use which is conditional on the child's diabetes etc), formal health care utilisation | 6 months, 1 year, 2 year, 5 year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT00328302 -
Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy
|
Phase 4 | |
Completed |
NCT00541515 -
Closing the Loop Between Glucose Sensor and Insulin Pump-developing an Algorithm
|
N/A | |
Completed |
NCT00810589 -
A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial
|
Phase 1 | |
Completed |
NCT00046150 -
12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.
|
Phase 3 | |
Terminated |
NCT01129232 -
Diabetes Virus Detection Project, Intervention With GAD-alum
|
Phase 2 | |
Completed |
NCT00308308 -
Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes
|
Phase 3 | |
Completed |
NCT00654121 -
Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives
|
Phase 2 | |
Completed |
NCT01754259 -
Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
|
Phase 3 |